ArticleCancers2023

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.

Ewan Hunter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.